What is the main business of Thermalia?

The main business activity of Thermalia focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on May 29, 2018.

Where is the headquarters located?

The headquarters is located at: ul. Juliusza Lea 19A, 30-048 Kraków.

What is the share capital?

The share capital of the company is PLN 5,000 (approx. $1,351).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.

What revenue was generated?

The company reported a revenue of $12 in 2024.

Is the company profitable?

No, the company recorded a net loss of $1,272 in 2024. For comparison, in 2023 the loss was $1,407, meaning the company reduced its loss by 14.1%.

What is the main operating cost?

The largest operating cost category falls under external services. This category amounted to $912 in 2024, representing 87% of all operating expenses.

Thermaliasp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2018-05-29

Share capital

5,000.00 PLN

Registered address

ul. Juliusza Lea 19A/7, 30-048 Kraków, Poland

Electronic delivery address

AE:PL-53421-22504-DHGIJ-30

Financials

Revenue history

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 2 of 6 financial statements were filed late (the longest delay 91 days for 2021).

2025not filed
202414/07/2025
202314/07/2024
202216/07/2023
202114/10/2022
202014/10/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Research and experimental development on biotechnology353 / 386

Top 91%

Division · Scientific research and development1,833 / 1,953

Top 94%

Sector · Professional, scientific and technical activities37,808 / 39,211

Top 96%

Voivodeship · Małopolskie44,160 / 46,035

Top 96%

Country · Poland475,338 / 495,867

Top 96%

Results vs industry

Revenue

This companyUSD 12.15MedianUSD 55.66kAverageUSD 2.70m

Net profit

This companyUSD -1.27kMedianUSD -1.27kAverageUSD -92.16k

Operating costs

This companyUSD 1.05kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 1.61kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Krzysztof Franciszek Mańkowski – President of the Management Board

Manner of representation

The company may be represented in non-property matters and in property matters by each member of the management board independently.

Ownership

Owner	Shares	Share value	Stake
Maria Athina Mańkowskaage 40	50	$675.31	50%
Krzysztof Franciszek Mańkowskiage 49	50	$675.31	50%

Krzysztof Franciszek Mańkowski and Maria Athina Mańkowska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person	Rights

Bank accounts

Was a VAT taxpayer from 2020-10-01 to 2021-06-01.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
MedappS.A.	$3,351,163.61	medapp.pl
SkinlabP.S.A.	$1,797,229.06	skinlab.pl
EIT Rawmaterials Clc Eastsp. z o.o.	$1,795,803.10	eitrawmaterials.eu
COS LabP.S.A.	$1,028,123.83	coslab.pl
IntelliseqS.A.	$111,419.60	intelliseq.pl
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.	$54,163.54	geneza.eu
Medtransfersp. z o.o.	$21,666.01	codete.com
Oncotherics PolandS.A.	$7,565.33	oncotherics.com
Fusiomicasp. z o.o.	$5,263.98	fusiomica.com
Ncage TherapeuticsS.A.	$29.14	ncage.org

Change history

Date	Event
2020-09-25	PKD change (Removed: 6 codes; Added: 10 codes)
2018-05-29	Entered in the register

FAQ

Last updated: 2026-04-02